Alembic Pharma gets USFDA nod for hypertension drug

The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Candesartan Cilexetil tablets USP in the strengths of 4 mg, 8 mg, and 16 mg, Alembic Pharmaceuticals said in a filing to BSE.

from Moneycontrol Business News https://ift.tt/2RCgZYQ